Early remodeling and loss of light-induced dilation of retinal small arteries in CADASIL.

CADASIL adaptive optics functional remodeling retinal vessels

Journal

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
ISSN: 1559-7016
Titre abrégé: J Cereb Blood Flow Metab
Pays: United States
ID NLM: 8112566

Informations de publication

Date de publication:
13 Jan 2024
Historique:
medline: 13 1 2024
pubmed: 13 1 2024
entrez: 13 1 2024
Statut: aheadofprint

Résumé

A major hurdle to therapeutic development in cerebral small vessel diseases is the lack of in-vivo method that can be used repeatedly for evaluating directly cerebral microvessels. We hypothesised that Adaptive Optics (AO), which allows resolution images up to 1-2 μm/pixel at retinal level, could provide a biomarker for monitoring vascular changes in CADASIL, a genetic form of such condition. In 98 patients and 35 healthy individuals, the wall to lumen ratio (WLR), outer and inner diameter, wall thickness and wall cross-sectional area were measured in a parapapillary and/or paramacular retinal artery. The ratio of vessel diameters before and after light flicker stimulations was also calculated to measure vasoreactivity (VR). Multivariate mixed-model analysis showed that WLR was increased and associated with a larger wall thickness and smaller internal diameter of retinal arteries in patients. The difference was maximal at the youngest age and gradually reduced with aging. Average VR in patients was less than half of that of controls since the youngest age. Any robust association was found with clinical or imaging manifestations of the disease. Thus, AO enables the detection of early functional or structural vascular alterations in CADASIL but with no obvious link to the clinical or imaging severity.

Identifiants

pubmed: 38217411
doi: 10.1177/0271678X241226484
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

271678X241226484

Déclaration de conflit d'intérêts

Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Auteurs

Michel Paques (M)

Paris Eye Imaging Group, Clinical Investigation Center 1423, Quinze-Vingts Hospital, Sorbonne Université, INSERM, Paris, France.

Valérie Krivosic (V)

Paris Eye Imaging Group, Clinical Investigation Center 1423, Quinze-Vingts Hospital, Sorbonne Université, INSERM, Paris, France.
Ophthalmology Department, Hôpital Lariboisière, APHP and Université Paris-Cité, France.
Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Œil (CERVCO), Hôpital Lariboisière, Paris, AP-HP, France.

Daniela Castro-Farias (D)

Paris Eye Imaging Group, Clinical Investigation Center 1423, Quinze-Vingts Hospital, Sorbonne Université, INSERM, Paris, France.

Cédric Dulière (C)

Paris Eye Imaging Group, Clinical Investigation Center 1423, Quinze-Vingts Hospital, Sorbonne Université, INSERM, Paris, France.

Dominique Hervé (D)

Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Œil (CERVCO), Hôpital Lariboisière, Paris, AP-HP, France.
Translational Neurovascular Centre and Departement of Neurology, FHU NeuroVasc, Paris, France.

Céline Chaumette (C)

Paris Eye Imaging Group, Clinical Investigation Center 1423, Quinze-Vingts Hospital, Sorbonne Université, INSERM, Paris, France.

Florence Rossant (F)

Institut Superieur d'Electronique de Paris, Paris, France.

Abbas Taleb (A)

Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Œil (CERVCO), Hôpital Lariboisière, Paris, AP-HP, France.

Jessica Lebenberg (J)

Translational Neurovascular Centre and Departement of Neurology, FHU NeuroVasc, Paris, France.
Université Paris-Cité, Inserm, NeuroDiderot, U1141, Paris, France.

Eric Jouvent (E)

Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Œil (CERVCO), Hôpital Lariboisière, Paris, AP-HP, France.
Translational Neurovascular Centre and Departement of Neurology, FHU NeuroVasc, Paris, France.
Université Paris-Cité, Inserm, NeuroDiderot, U1141, Paris, France.

Ramin Tadayoni (R)

Paris Eye Imaging Group, Clinical Investigation Center 1423, Quinze-Vingts Hospital, Sorbonne Université, INSERM, Paris, France.
Ophthalmology Department, Hôpital Lariboisière, APHP and Université Paris-Cité, France.
Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Œil (CERVCO), Hôpital Lariboisière, Paris, AP-HP, France.

Hugues Chabriat (H)

Centre de Référence des Maladies Vasculaires Rares du Cerveau et de l'Œil (CERVCO), Hôpital Lariboisière, Paris, AP-HP, France.
Translational Neurovascular Centre and Departement of Neurology, FHU NeuroVasc, Paris, France.
Université Paris-Cité, Inserm, NeuroDiderot, U1141, Paris, France.

Classifications MeSH